Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Sep 14, 2009; 15(34): 4225-4233
Published online Sep 14, 2009. doi: 10.3748/wjg.15.4225
Published online Sep 14, 2009. doi: 10.3748/wjg.15.4225
Drugs that increase CNI levels |
Macrolides: clarithromycin, erythromycin, azithromycin |
Antifungals: fluconazole, itraconazole, ketoconazole, voriconazole, clotrimazole |
Calcium channel blockers: verapamil, diltiazem, nifedipine |
Others: cisapride, metaclopramide, amiodarone, cimetidine, protease inhibitors |
Drugs that decrease CNI and sirolimus levels |
Antibiotics: rifabutin, rifampin |
Anticonvulsants: carbamazepine, phenobarbital, phenytoin, fosphenytoin |
Others: St. John’s Wort |
Drug | Adverse effects |
Tacrolimus | Nephrotoxicity, neurotoxicity1, diabetes1, hyperkalemia, metabolic acidosis, hypertension, hyperlipidemia |
Cyclosporine | Nephrotoxicity, neurotoxicity, diabetes, hyperlipidemia1, hypertension1, hyperkalemia, metabolic acidosis, gingival hyperplasia, hypertrichosis |
MMF | Myelosuppression, gastrointestinal side effects, viral infections (CMV, HSV), spontaneous abortions in pregnant women |
Sirolimus | Hyperlipidemia, myelosuppression, proteinuria, poor wound healing, pneumonitis, skin rash |
Corticosteroids | Diabetes, hypertension, obesity, osteoporosis, avascular necrosis, growth retardation, Cushingoid features, psychosis, poor wound healing, adrenal suppression, cataracts |
- Citation: Pillai AA, Levitsky J. Overview of immunosuppression in liver transplantation. World J Gastroenterol 2009; 15(34): 4225-4233
- URL: https://www.wjgnet.com/1007-9327/full/v15/i34/4225.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.4225